Tardive Dyskinesia and the 3-Year Course of Schizophrenia: Results From a Large, Prospective, Naturalistic Study

被引:45
|
作者
Ascher-Svanum, Haya [1 ]
Zhu, Baojin [1 ]
Faries, Douglas [1 ]
Peng, Xiaomei [1 ]
Kinon, Bruce J. [1 ]
Tohen, Mauricio [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, US Outcomes Res, Indianapolis, IN 46285 USA
关键词
D O I
10.4088/JCP.v69n1008
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Objective: The objective of this Study was to compare the 3-year course of schizophrenia between persons with tardive dyskinesia (TD) and Persons Without TD on multiple outcome Measures. Method: Data were drawn from a large, prospective, naturalistic study of persons treated for schizophrenia-spectrum disorders (DSM-IV criteria) in the United States. conducted between July 1997 and September 2003. Treatment outcomes were assessed at enrollment and at 12, 24 and 36 months postenrollment using measures of symptoms, functioning productivity, activity, and quality of life. Participants who had TD at enrollment (fulfilling Schooler-Kane criteria, N = 637) were compared with those who did not (N = 1538) on Clinical and functional measures at enrollment and across the 3 years of follow-up. Additional analyses examined those with persistent TD compared to those without persistent TD. Results: With adjustment for known correlates of TD, participants with TD compared to those without TD had significantly more severe psychopathology were less likely to experience symptom remission, had more severe extrapyramidal side effects, and had tower levels of quality of life and functioning, lower productivity, and fewer activities (all p < .001 across thee 3-year follow-up. Findings were essentially unchanged when the subgroup of participants with persistent TD (at enrollment and at 1 year) was examined. Conclusion: These results, indicate that, in the long-term treatment of schizophrenia, persons with TD have a significanly more severe and more refractory course of illness than those without TD, suggesting poorer prognosis and the need for specialized interventions. (J Clin Psychiatry 2008:69:1580-1588)
引用
收藏
页码:1580 / 1588
页数:9
相关论文
共 50 条
  • [1] The 3-year course of schizophrenia among persons with tardive dyskinesia and persons without
    Ascher-Svanum, Haya
    Zhu, Baojin
    Faries, Douglas
    Kinon, Bruce
    Tohen, Mauricio
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S73 - S73
  • [2] The 3-year course of schizophrenia among persons with tardive dyskinesia and persons without
    Ascher-Svanum, H
    Zhu, BJ
    Faries, DE
    Kinon, BJ
    Tohen, M
    [J]. BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 205S - 205S
  • [4] TARDIVE-DYSKINESIA - A 3-YEAR FOLLOW-UP-STUDY
    BARNES, TRE
    KIDGER, T
    GORE, SM
    [J]. PSYCHOLOGICAL MEDICINE, 1983, 13 (01) : 71 - 81
  • [5] Olanzapine improves tardive dyskinesia in patients with schizophrenia in a controlled prospective study
    Kinon, B
    Stauffer, V
    Wang, L
    Thi, K
    Kollack-Walker, S
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S255 - S256
  • [6] Olanzapine improves tardive dyskinesia in patients with schizophrenia in a controlled prospective study
    Kinon, BJ
    Stauffer, VL
    Thi, KT
    Kollack-Walker, S
    [J]. MOVEMENT DISORDERS, 2002, 17 : S329 - S329
  • [7] Tardive dyskinesia in the elderly: Data from a prospective study
    Kane, JM
    [J]. PSYCHIATRIC ANNALS, 2002, 32 (04) : 233 - 236
  • [8] INCIDENCE OF TARDIVE-DYSKINESIA - 5-YEAR DATA FROM A PROSPECTIVE-STUDY
    KANE, JM
    WOERNER, M
    WEINHOLD, P
    WEGNER, J
    KINON, B
    BORENSTEIN, M
    [J]. PSYCHOPHARMACOLOGY BULLETIN, 1984, 20 (03) : 387 - 389
  • [9] Tardive dyskinesia in patients with depressive disrder treated with flupentixlmelitracin - results from a 12-month, prospective, open study under naturalistic conditions in Bangladesh
    Haque, Rashimul
    Kabir, Kaniza
    [J]. MOVEMENT DISORDERS, 2016, 31 : S69 - S69
  • [10] Clinical and ultrasonographic predictors of joint replacement for knee osteoarthritis: results from a large, 3-year, prospective EULAR study
    Conaghan, P. G.
    D'Agostino, M. A.
    Le Bars, M.
    Baron, G.
    Schmidely, N.
    Wakefield, R.
    Ravaud, P.
    Grassi, W.
    Martin-Mola, E.
    So, A.
    Backhaus, M.
    Malaise, M.
    Emery, P.
    Dougados, M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (04) : 644 - 647